Perfluorinated Chemicals and Fetal Growth: A Study within the Danish National Birth Cohort
Top Cited Papers
- 1 November 2007
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 115 (11), 1677-1682
- https://doi.org/10.1289/ehp.10506
Abstract
Perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) are man-made, persistent organic pollutants widely spread throughout the environment and human populations. They have been found to interfere with fetal growth in some animal models, but whether a similar effect is seen in humans is uncertain. We investigated the association between plasma levels of PFOS and PFOA in pregnant women and their infants' birth weight and length of gestation. We randomly selected 1,400 women and their infants from the Danish National Birth Cohort among those who completed all four computer-assisted telephone interviews, provided the first blood samples between gestational weeks 4 and 14, and who gave birth to a single live-born child without congenital malformation. PFOS and PFOA were measured by high performance liquid chromatography-tandem mass spectrometer. PFOS and PFOA levels in maternal plasma were on average 35.3 and 5.6 ng/mL, respectively. Only PFOA levels were inversely associated with birth weight (adjusted beta = -10.63 g; 95% confidence interval, -20.79 to -0.47 g). Neither maternal PFOS nor PFOA levels were consistently associated with the risk for preterm birth or low birth weight. We observed no adverse effects for maternal PFOS or PFOA levels on small for gestational age. Our nationwide cohort data suggest an inverse association between maternal plasma PFOA levels and birth weight. Because of widespread exposure to these chemicals, our findings may be of potential public health concern.Keywords
This publication has 40 references indexed in Scilit:
- Cord Serum Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in Relation to Weight and Size at BirthEnvironmental Health Perspectives, 2007
- Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production WorkersEnvironmental Health Perspectives, 2007
- Self-Reported Medical Conditions in Perfluorooctanesulfonyl Fluoride Manufacturing WorkersJournal of Occupational and Environmental Medicine, 2007
- Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicalsEnvironmental Research, 2007
- Exposure of Perfluorinated Chemicals through Lactation: Levels of Matched Human Milk and Serum and a Temporal Trend, 1996–2004, in SwedenEnvironmental Health Perspectives, 2007
- The Applicability of Biomonitoring Data for Perfluorooctanesulfonate to the Environmental Public Health ContinuumEnvironmental Health Perspectives, 2006
- Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health ParametersJournal of Occupational and Environmental Medicine, 2006
- Community Exposure to Perfluorooctanoate: Relationships Between Serum Concentrations and Exposure SourcesJournal of Occupational and Environmental Medicine, 2006
- Prenatal window of susceptibility to perfluorooctane sulfonate‐induced neonatal mortality in the Sprague‐Dawley ratBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
- Rat and Rabbit Oral Developmental Toxicology Studies With Two Perfluorinated CompoundsInternational Journal of Toxicology, 2001